Research Analysts’ Weekly Ratings Updates for Phibro Animal Health Corporation (PAHC)

Several brokerages have updated their recommendations and price targets on shares of Phibro Animal Health Corporation (NASDAQ: PAHC) in the last few weeks:

  • 8/31/2017 – Phibro Animal Health Corporation had its price target raised by analysts at Credit Suisse Group from $36.00 to $37.00. They now have an “outperform” rating on the stock.
  • 8/31/2017 – Phibro Animal Health Corporation had its “buy” rating reaffirmed by analysts at Piper Jaffray Companies. They now have a $41.00 price target on the stock, down previously from $42.00.
  • 8/25/2017 – Phibro Animal Health Corporation was given a new $42.00 price target on by analysts at Piper Jaffray Companies. They now have a “buy” rating on the stock.
  • 8/23/2017 – Phibro Animal Health Corporation was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 8/23/2017 – Phibro Animal Health Corporation had its “underperform” rating reaffirmed by analysts at Bank of America Corporation. They now have a $33.00 price target on the stock.
  • 7/21/2017 – Phibro Animal Health Corporation was given a new $35.00 price target on by analysts at Piper Jaffray Companies. They now have a “buy” rating on the stock.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.83% during trading on Tuesday, reaching $36.55. The company’s stock had a trading volume of 167,075 shares. The stock’s 50 day moving average price is $38.25 and its 200-day moving average price is $33.63. The firm has a market cap of $1.45 billion, a PE ratio of 22.70 and a beta of 1.36. Phibro Animal Health Corporation has a 12 month low of $24.83 and a 12 month high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The firm had revenue of $194.84 million for the quarter, compared to analysts’ expectations of $192.47 million. During the same quarter last year, the firm earned $0.32 EPS. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. Equities analysts predict that Phibro Animal Health Corporation will post $1.57 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be paid a dividend of $0.10 per share. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 annualized dividend and a dividend yield of 1.09%. Phibro Animal Health Corporation’s payout ratio is currently 24.69%.

In other news, VP Daniel M. Bendheim sold 5,938 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $40.04, for a total transaction of $237,757.52. Following the completion of the sale, the vice president now owns 300 shares in the company, valued at approximately $12,012. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, major shareholder Bfi Co., Llc sold 48,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.82, for a total transaction of $1,671,360.00. Following the sale, the insider now owns 96,000 shares of the company’s stock, valued at approximately $3,342,720. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 282,923 shares of company stock valued at $10,310,877. 48.09% of the stock is currently owned by company insiders.

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply